
JPXIndustrialsSpecialty Business Services
Latest quote
¥257
−¥9.00 · -3.38%
Operating from Tokyo, Japan since its establishment in 2012, Tsubota Laboratory Incorporated is dedicated to the research and development of pharmaceutical products and medical devices, specifically targeting the treatment of myopia, dry eyes, and presbyopia.
Latest quote
¥257
−¥9.00 · -3.38%
Regular session · JST · Market data may be delayed.
Operating from Tokyo, Japan since its establishment in 2012, Tsubota Laboratory Incorporated is dedicated to the research and development of pharmaceutical products and medical devices, specifically targeting the treatment of myopia, dry eyes, and presbyopia.
Day range
Current ¥257
52-week range
Current ¥257
Regular session · JST · Market data may be delayed.
Operating from Tokyo, Japan since its establishment in 2012, Tsubota Laboratory Incorporated is dedicated to the research and development of pharmaceutical products and medical devices, specifically targeting the treatment of myopia, dry eyes, and presbyopia.
Day range
Current ¥257
52-week range
Current ¥257
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 200.02M JPY | 1.36B JPY | 673.53M JPY | 954.69M JPY | 640.92M JPY |
| Cost of goods sold | 68.45M JPY | 204.54M JPY | 683.02M JPY | 267.86M JPY | 112.16M JPY |
| Gross profit | 131.57M JPY | 1.15B JPY | −9.48M JPY | 686.83M JPY | 528.76M JPY |
| Research and development | — | 254.11M JPY | 205.3M JPY | 126.27M JPY | 116.97M JPY |
| Selling, general, and administrative | 917.8M JPY | 661.43M JPY | 427.23M JPY | 393.54M JPY | 275.62M JPY |
| Operating expenses | 917.8M JPY | 915.54M JPY | 632.52M JPY | 519.8M JPY | 392.59M JPY |
| Interest income | 3.05M JPY | 961K JPY | 18K JPY | 18K JPY | 11K JPY |
| Interest expense | 698K JPY | 1.09M JPY | 1M JPY | 778K JPY | 1.03M JPY |
| Depreciation and amortization | 20.99M JPY | 25.4M JPY | 32.77M JPY | 39.19M JPY | 37.7M JPY |
| Operating income | −786.23M JPY | 237.05M JPY | −642.01M JPY | 167.03M JPY | 136.17M JPY |
| Net income | −761.82M JPY | 205.77M JPY | −641.32M JPY | 90.18M JPY | 153.32M JPY |
Company facts updated Sep 11, 2026.
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.